GRAP and prostate cancer: miR-654-5p has been reported to promote carcinoma proliferation in oral squamous cell through the miR-654-5p/GRAP/Ras/Erk signalling pathway [32], and down-regulation of miR-654-5p inhibited the proliferation of prostate cancer cells [33].